CollPlant Biotechnologies (CLGN) Current Deferred Revenue (2018 - 2021)
CollPlant Biotechnologies (CLGN) posted Current Deferred Revenue of $32000.0 for Q4 2021, down 80.49% on a QoQ basis from $164000.0 in Q1 2021, and down 84.54% year-over-year from $207000.0 in Q4 2020.
CollPlant Biotechnologies (CLGN) Current Deferred Revenue (2018 - 2021) Analysis & Trends
CollPlant Biotechnologies' Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $32000.0 for Q4 2021.
- Quarterly Current Deferred Revenue fell 84.54% year-over-year to $32000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $32000.0 (down 84.54% YoY) and the FY2021 annual result came in at $32000.0, down 84.54% from the prior year.
- Current Deferred Revenue was $32000.0 for Q4 2021 at CollPlant Biotechnologies, down from $164000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $1.3 million in Q1 2019 and bottomed at $32000.0 in Q4 2021.
- A 4-year average of $658363.6 and a median of $687000.0 in 2020 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2019 — Current Deferred Revenue dropped 3.88% — and 2021, when it tumbled 84.54%.
- CollPlant Biotechnologies' Current Deferred Revenue stood at $980000.0 in 2018, then decreased by 3.88% to $942000.0 in 2019, then plunged by 78.03% to $207000.0 in 2020, then tumbled by 84.54% to $32000.0 in 2021.
- Business Quant data shows CLGN's Current Deferred Revenue at $32000.0 in Q4 2021, $164000.0 in Q1 2021, and $207000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 32,000.00 |
| Mar 31, 2021 | 164,000.00 |
| Dec 31, 2020 | 207,000.00 |
| Sep 30, 2020 | 317,000.00 |
| Jun 30, 2020 | 297,000.00 |
| Mar 31, 2020 | 687,000.00 |
| Dec 31, 2019 | 942,000.00 |
| Sep 30, 2019 | 1.11 Mn |
| Jun 30, 2019 | 1.24 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 980,000.00 |